Accela Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Pune, Maharashtra, India, established in 2010.
2010 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Accela Pharmaceuticals Private Limited

Accela Pharmaceuticals Private Limited, a active private limited company, was established on 05 July 2010 in Pune, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24232PN2010PTC136759. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.15 M.

It upholds a compliant status. Its leadership includes Pragati Dinesh Bothara (Director), Dinesh Keshari Chand Bothra (Director). Past directors included Dineshchand Hirachand Munot, Viraj Dhirubhai Shah, Pragati Dinesh Bothara. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at S No. 118 To 124, Plot No 98, National Soc, Aundh,, Pune, Maharashtra, 411021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232PN2010PTC136759

  • Registration Number

    136759

  • Incorporation Date

    05 July 2010

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.15 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 15 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -31.03%
  • Profit Growth **** -34.57%
  • Ebitda **** -32.48%
  • Net Worth 16.13%
  • Total Assets -28.73%
Company report

Accela Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Accela Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Accela Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Pragati Dinesh Bothara Director 30 Mar 2022 Current
Dinesh Keshari Chand Bothra Director 05 Jul 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Apr 2015 Past
Pramod Abcsdd Director 19 Apr 2022 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Additional Director 16 Sep 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Accela Pharmaceuticals.

Accela Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.03% decrease. The company also saw a substantial fall in profitability, with a 34.57% decrease in profit. The company's net worth Soared by an impressive increase of 16.13%.

Accela Pharmaceuticals revenue growth over time
Accela Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -31.03%
*******
*******
*******
*******
Revenue from Operations
*******
 -31.03%
*******
*******
*******
*******
Total Assets
*******
 -28.73%
*******
*******
*******
*******
Profit or Loss
*******
 -34.57%
*******
*******
*******
*******
Net Worth
*******
 16.13%
*******
*******
*******
*******
EBITDA
*******
 -32.48%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Accela Pharmaceuticals?

Unlock access to Accela Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Accela Pharmaceuticals?

Unlock and access historical data on people associated with Accela Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Accela Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accela Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Accela Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Accela Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Accela Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.

  • Director Appointment

    Progress on Pragati Dinesh Bothara was appointed as a Director was appointed as a Director on 30 Mar 2022 & has been associated with this company since 3 years 11 months . was documented.

  • Director Appointment

    The activity Dinesh Keshari Chand Bothra was appointed as a Director was appointed as a Director on 05 Jul 2010 & has been associated with this company since 15 years 8 months . was completed.

  • Company Incorporation

    Progress on Accela Pharmaceuticals Private Limited was registered on 05 Jul 2010 with Roc Pune & aged 15 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Accela Pharmaceuticals Private Limited?

The CIN of Accela Pharmaceuticals Private Limited is U24232PN2010PTC136759.

Where is Accela Pharmaceuticals Private Limited headquartered?

Accela Pharmaceuticals Private Limited is headquartered at S No. 118 To 124, Plot No 98, National Soc, Aundh,, Pune, Maharashtra, 411021.

When was Accela Pharmaceuticals Private Limited incorporated?

Accela Pharmaceuticals Private Limited was incorporated on 05 July 2010.

Who are the current directors of Accela Pharmaceuticals Private Limited?

The current directors of Accela Pharmaceuticals Private Limited are

What is the primary industry of Accela Pharmaceuticals Private Limited?

The primary industry of Accela Pharmaceuticals Private Limited is Professional, Scientific And Technical.

Is Accela Pharmaceuticals Private Limited a listed company?

Accela Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Accela Pharmaceuticals Private Limited?

The authorized capital of Accela Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.15 M.

What is the compliance status of Accela Pharmaceuticals Private Limited?

The compliance status of Accela Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available